ClinicalTrials.gov
ClinicalTrials.gov Menu

Remifentanil in Extracorporeal Shock Wave Lithotripsy (ESWL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01452880
Recruitment Status : Completed
First Posted : October 17, 2011
Last Update Posted : October 17, 2011
Sponsor:
Information provided by (Responsible Party):
Francesco Cannata, University of Roma La Sapienza